Chromation is a product stage start-up, founded in 2010 and spun out of Columbia University. The company specializes in surface mount UV-VIS-NIR spectrometer chips and has a proprietary spectrometer (sensor) technology suitable for integrated and implantable testing applications. Chromation is currently focused on developing a spectroscopic test for detection of infections associated with medical implants. The company is headquartered in the United States and recently received a $1.70M Venture Round investment on 28 June 2018. This investment signifies a vote of confidence in the potential of Chromation's innovative technology and its applications in the medical and testing industries.
No recent news or press coverage available for Chromation.